Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2015-02-13 | Christopher Missling, age 49, has over twenty (20) years of healthcare industry experience in big pharmaceutical, biotech industry and investment banking. Mr. Missling earned his MS and PhD from the University of Munich and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management. |
| 2018-03-08 | Christopher Missling, age 52, has over 20 years of healthcare industry experience in the big pharmaceutical, biotech and investment banking industries. Dr. Missling earned his MS and PhD from the University of Munich and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management. |
| 2019-02-11 | Christopher Missling, age 53, has over 20 years of healthcare industry experience in the big pharmaceutical, biotech and investment banking industries. ... Dr. Missling earned his MS and PhD from the University of Munich and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management. |
| 2020-02-20 | Christopher Missling, age 54, has over twenty years of healthcare industry experience in big pharmaceutical, biotech industry and investment banking. Dr. Missling earned his MS and PhD from the University of Munich and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management. |
| 2021-04-12 | Christopher Missling, age 55, has over twenty years of healthcare industry experience in big pharmaceutical, biotech industry and investment banking. Dr. Missling earned his MS and PhD from the University of Munich and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management. |
| 2022-04-11 | Christopher Missling, age 56, has over twenty years of healthcare industry experience in big pharmaceutical, biotech industry and investment banking. Dr. Missling earned his MS and PhD from the University of Munich and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management. |
| 2023-04-04 | Christopher Missling, age 57, has over twenty years of healthcare industry experience in big pharmaceutical, biotech industry and investment banking. Dr. Missling earned his MS and PhD from the University of Munich and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management. |
| 2024-05-06 | Christopher Missling, age 58, has over twenty years of healthcare industry experience in big pharmaceutical, biotech and investment banking. Most recently, from March 2007 until his appointment by our Company, Dr. Missling served as the head of healthcare investment banking at Brimberg & Co. in New York, New York. In addition, Dr. Missling served as the Chief Financial Officer of Curis, Inc. (NASDAQ: CRIS) and ImmunoGen, Inc. (NASDAQ: IMGN). Dr. Missling earned his MS and PhD from the University of Munich and an MBA from Northwestern University Kellogg School of Management and WHU Otto Beisheim School of Management. |
Data sourced from SEC filings. Last updated: 2026-03-05